CBW Fentanyl Act
- Bill Number
- S. 63
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2025-01-09: Read twice and referred to the Committee on Foreign Relations.
- Last Updated
- 2026-03-24T01:21:58Z
AI-Generated Summary
Purpose
The legislation amends the Chemical and Biological Weapons Control and Warfare Elimination Act of 1991 to expand U.S. sanctions authority. Its main goal is to deter and punish foreign governments or entities involved in chemical or biological programs—particularly those related to fentanyl precursors—that cause harm or injury to other countries. This includes acts that knowingly lead to damage, such as through the production or distribution of harmful substances. The bill specifically targets "weaponization" of fentanyl, a synthetic opioid linked to overdose deaths, by imposing escalating economic and trade penalties.
Key Provisions
- Expanded Purposes (Section 2): Updates the Act's objectives to include sanctions against countries that violate international chemical or biological laws, use such weapons against nationals, or commit acts via chemical/biological programs causing injury to other nations.
- Presidential Reporting and Determinations (Section 3):
- Requires the President to investigate credible reports of "covered acts" (harmful actions by foreign officials, employees, or agents tied to chemical/biological programs) within 60 days.
- Mandates reports to Congress detailing evidence, such as physical proof, program purposes (civilian vs. military), concealment efforts, voluntary disclosures, and compliance with treaties like the Biological Weapons Convention and Chemical Weapons Convention.
- Specifies sanctions under a new Section 310 if a covered act is confirmed.
- Sanctions on Foreign Countries (Section 4, New Section 310):
- Initial Sanctions (within 30 days): Applied to the country most associated with the offending entity; includes suspending U.S. scientific cooperation, banning exports of certain controlled items (e.g., under Commerce Control List Categories 1 and 2, which cover chemicals and materials), and prohibiting U.S. procurement from that country's chemical or biological sectors.
- Intermediate Sanctions (after 120 days): If the country fails to address the act, provide information, or prevent future incidents (per a congressional report), at least two additional measures are required, such as cutting non-humanitarian foreign aid, broader export bans (under laws like the Export Control Reform Act), or blocking arms export licenses.
- Final Sanctions (after 210 days): If issues persist, bans all U.S.-jurisdictional financial transactions involving the country's interests (e.g., commerce or banking).
- Termination: Sanctions end after one year if the country addresses the harm, provides restitution (including to U.S. citizens), shares information, prevents recurrence, and complies with relevant treaties.
- Waiver: The President can pause sanctions for up to 180 days if vital to U.S. national security, but this authority expires five years after enactment.
- Definitions (Section 4, New Section 311):
- Chemical or Biological Program: Covers development, production, or distribution of weapons, or specific fentanyl-related chemicals (e.g., benzylfentanyl, 4-anilinopiperidine, norfentanyl precursors—key ingredients in illicit fentanyl).
- Covered Act: A knowing action by a foreign government-linked individual causing injury to another country via such a program.
- Other terms include "foreign governmental entity" (broadly covering governments, agencies, or supported entities) and "covered treaties" (international bans on biological and chemical weapons).
- Conforming Amendment (Section 5): Minor update to align existing reporting requirements with the new provisions.
Significant Changes to Existing Law
- Broadens the 1991 Act beyond direct use of chemical/biological weapons (e.g., in warfare) to include broader "programs" causing indirect harm, like fentanyl distribution leading to public health crises.
- Introduces tiered, time-bound sanctions with mandatory escalation, unlike the original Act's more flexible approach.
- Adds fentanyl-specific precursors as sanctionable items, linking chemical weapons controls to the opioid epidemic.
- Requires explicit presidential certifications for waivers and terminations, increasing congressional oversight.
- Expands reporting to consider factors like evidence concealment and treaty compliance, providing a structured framework for decisions.
Potential Impacts
- Government Agencies: Increases workload for the State Department (foreign relations committees), Commerce Department (export controls), and the President (determinations and waivers); may strain diplomatic resources for investigations and enforcement.
- Citizens: U.S. citizens harmed by covered acts (e.g., fentanyl victims) could benefit from required restitution; however, sanctions might raise costs for imported goods or services from affected countries, indirectly affecting consumers.
- International Relations: Could escalate tensions with targeted nations (e.g., implied focus on China via the bill's title), disrupt global trade in chemicals and pharmaceuticals, and pressure compliance with arms control treaties; may strengthen U.S. alliances by deterring cross-border harms like drug trafficking.
Main Stakeholders Affected
- U.S. Government: Executive branch (President, State, Commerce, Treasury Departments) for implementation; Congress (Foreign Relations and Foreign Affairs Committees) for oversight and reports.
- Foreign Governments and Entities: Primarily those with chemical/biological programs (e.g., state-linked producers of fentanyl precursors), facing economic isolation if non-compliant.
- International Organizations: Bodies overseeing treaties (e.g., Organisation for the Prohibition of Chemical Weapons) benefit from required disclosures.
- Citizens and Businesses: U.S. firms in science, exports, and procurement sectors may face restrictions; citizens in harmed countries (e.g., fentanyl-affected nations like the U.S. or Mexico) gain potential protections and restitution; global pharmaceutical and chemical industries could see disrupted supply chains.
Notable Legal, Constitutional, or Political Implications
- Legal: Enhances enforceability of international treaties by tying them to domestic sanctions, potentially setting precedents for hybrid threats (e.g., drugs as "weapons"); defines broad terms like "injury" and "foreign governmental entity," which could lead to legal challenges over scope or evidence standards.
- Constitutional: Relies on presidential foreign affairs powers (Article II) but mandates congressional reporting and limits waivers, balancing executive flexibility with legislative checks; avoids direct funding appropriations, focusing on regulatory actions.
- Political: Signals strong U.S. stance against state-sponsored drug threats, possibly as a tool in geopolitical rivalries (e.g., U.S.-China relations); could influence bilateral talks on opioids but risks retaliation or WTO disputes over trade barriers; promotes accountability for non-state harms under a weapons control framework.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Sen. Cotton, Tom [R-AR], Sen. Moreno, Bernie [R-OH]
Recent Actions
- 2025-01-09: Read twice and referred to the Committee on Foreign Relations.
- 2025-01-09: Introduced in Senate
Bill Versions
- Countering Beijing’s Weaponization of Fentanyl Act — issued 2025-01-09 — PDF (18 pages)